Molecular Mechanisms of Inflammation in Sarcopenia: Diagnosis and Therapeutic Update
Guadalupe Elizabeth Jimenez-Gutierrez,
Laura Edith Martínez-Gómez,
Carlos Martínez-Armenta,
Carlos Pineda,
Gabriela Angélica Martínez-Nava,
Alberto Lopez-Reyes
Affiliations
Guadalupe Elizabeth Jimenez-Gutierrez
Laboratorio de Gerociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Calz México-Xochimilco 289, Tlalpan, Mexico City 14389, Mexico
Laura Edith Martínez-Gómez
Laboratorio de Gerociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Calz México-Xochimilco 289, Tlalpan, Mexico City 14389, Mexico
Carlos Martínez-Armenta
Laboratorio de Gerociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Calz México-Xochimilco 289, Tlalpan, Mexico City 14389, Mexico
Carlos Pineda
Dirección General, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Calz México-Xochimilco 289, Tlalpan, Mexico City 14389, Mexico
Gabriela Angélica Martínez-Nava
Laboratorio de Gerociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Calz México-Xochimilco 289, Tlalpan, Mexico City 14389, Mexico
Alberto Lopez-Reyes
Laboratorio de Gerociencias, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Calz México-Xochimilco 289, Tlalpan, Mexico City 14389, Mexico
Sarcopenia is generally an age-related condition that directly impacts the quality of life. It is also related to chronic diseases such as metabolic dysfunction associated with diabetes and obesity. This means that everyone will be vulnerable to sarcopenia at some point in their life. Research to find the precise molecular mechanisms implicated in this condition can increase knowledge for the better prevention, diagnosis, and treatment of sarcopenia. Our work gathered the most recent research regarding inflammation in sarcopenia and new therapeutic agents proposed to target its consequences in pyroptosis and cellular senescence. Finally, we compared dual X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and ultrasound (US) as imaging techniques to diagnose and follow up on sarcopenia, indicating their respective advantages and disadvantages. Our goal is for the scientific evidence presented here to help guide future research to understand the molecular mechanisms involved in sarcopenia, new treatment strategies, and their translation into clinical practice.